ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 126 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,279 | -31.9% | 228,707 | -36.9% | 0.22% | -29.3% |
Q2 2023 | $19,502 | +24.7% | 362,291 | -8.0% | 0.31% | +22.9% |
Q1 2023 | $15,641 | -6.4% | 393,789 | -5.2% | 0.25% | -6.3% |
Q4 2022 | $16,707 | -99.9% | 415,280 | -0.2% | 0.27% | +16.9% |
Q3 2022 | $13,369,000 | +3.4% | 415,962 | -4.6% | 0.23% | +11.1% |
Q2 2022 | $12,932,000 | +8.5% | 435,873 | +2.8% | 0.21% | +22.4% |
Q1 2022 | $11,921,000 | -7.5% | 424,087 | +51.7% | 0.17% | -4.0% |
Q4 2021 | $12,882,000 | -12.9% | 279,554 | -37.9% | 0.18% | -16.9% |
Q3 2021 | $14,786,000 | +10.9% | 450,504 | +18.4% | 0.21% | +16.4% |
Q2 2021 | $13,336,000 | +12.3% | 380,474 | +15.8% | 0.18% | +8.3% |
Q1 2021 | $11,873,000 | +22.8% | 328,539 | -1.3% | 0.17% | +9.0% |
Q4 2020 | $9,665,000 | +1.7% | 332,807 | -1.3% | 0.16% | -15.8% |
Q3 2020 | $9,508,000 | -1.7% | 337,038 | +12.7% | 0.18% | -5.6% |
Q2 2020 | $9,668,000 | +5905.0% | 298,934 | +7483.3% | 0.20% | +4775.0% |
Q1 2020 | $161,000 | – | 3,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |